The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-ethylphenyl)-4-(3-hexylureido)benzenesulfonamide ID: ALA1077717
PubChem CID: 46882765
Max Phase: Preclinical
Molecular Formula: C21H29N3O3S
Molecular Weight: 403.55
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccc(CC)cc2)cc1
Standard InChI: InChI=1S/C21H29N3O3S/c1-3-5-6-7-16-22-21(25)23-18-12-14-20(15-13-18)28(26,27)24-19-10-8-17(4-2)9-11-19/h8-15,24H,3-7,16H2,1-2H3,(H2,22,23,25)
Standard InChI Key: FSTAEEBGFXLBHL-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
17.4415 -6.0891 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.8586 -6.8064 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.2713 -6.0866 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.2921 -8.4663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0053 -8.0534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7184 -8.4663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4316 -8.0534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1448 -8.4663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8580 -8.0534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5737 -8.4655 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2883 -8.0517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0039 -8.4638 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2873 -7.2259 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.7186 -8.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4334 -8.4642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1475 -8.0512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1470 -7.2245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4264 -6.8126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7151 -7.2281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5773 -7.2209 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2923 -6.8076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0065 -7.2216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7210 -6.8091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7211 -5.9825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0007 -5.5701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2892 -5.9850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4355 -5.5683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1514 -5.9799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14 15 2 0
4 5 1 0
15 16 1 0
8 9 1 0
16 17 2 0
3 2 2 0
17 18 1 0
9 10 1 0
18 19 2 0
19 14 1 0
17 2 1 0
5 6 1 0
2 20 1 0
10 11 1 0
20 21 1 0
21 22 2 0
11 12 1 0
22 23 1 0
6 7 1 0
23 24 2 0
11 13 2 0
24 25 1 0
2 1 2 0
25 26 2 0
26 21 1 0
12 14 1 0
24 27 1 0
7 8 1 0
27 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 403.55Molecular Weight (Monoisotopic): 403.1930AlogP: 4.75#Rotatable Bonds: 10Polar Surface Area: 87.30Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.04CX Basic pKa: ┄CX LogP: 4.76CX LogD: 4.68Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.50Np Likeness Score: -1.52
References 1. Pasternak A, Goble SD, deJesus RK, Hreniuk DL, Chung CC, Tota MR, Mazur P, Feighner SD, Howard AD, Mills SG, Yang L.. (2009) Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists., 19 (21): [PMID:19767208 ] [10.1016/j.bmcl.2009.08.076 ]